Evidence map›Paper›PMID 30680942›Full record

ArticleThe journal of pathology. Clinical research2019

Training and accreditation standards for pathologists undertaking clinical trial work.

Gabrielle Rees, Manuel Salto-Tellez, Jessica L Lee, Karin Oien, Clare Verrill, Alex Freeman, Ilaria Mirabile, Nicholas P West, National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group

Abstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Slide-to-Slide Tissue Transfer and Array Assembly From Limited Samples for Comprehensive Molecular Profiling.Laboratory investigation; a journal of technical methods and pathology · 2023
    Article
  6. Review
  7. Review
  8. The use of digital pathology and image analysis in clinical trials.The journal of pathology. Clinical research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gabrielle ReesDepartment of Cellular Pathology, John Radcliffe Hospital, Oxford, UK.
Manuel Salto-TellezNorthern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University, Belfast, UK.
Jessica L LeeStrategy and Initiatives, National Cancer Research Institute, London, UK.
Karin OienInstitute of Cancer Sciences - Pathology, University of Glasgow, Glasgow, UK.
Clare VerrillNuffield Department of Surgical Sciences, University of Oxford, and Oxford NIHR Biomedical Research Centre, Oxford, UK.
Alex FreemanDepartment of Pathology, University College London Hospitals NHS Foundation Trust, London, UK.
Ilaria MirabileECMC Programme Office, Experimental Cancer Medicine Centres (ECMCs) Network, London, UK.
Nicholas P WestPathology and Data Analytics, Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.ORCID 0000-0002-0346-6709
National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group

Funding

Blood Cancer UKBreast Cancer NowCancer Research UK 25351Medical Research Council MR/N005813/1Medical Research Council MR/N005872/1Prostate Cancer UKYorkshire Cancer Research
6 · The paper itself

Abstract

Clinical trials rely on multidisciplinary teams for successful delivery. Pathologists should be involved in clinical trial design from the outset to ensure that protocols are optimised to deliver maximum data collection and translational research opportunities. Clinical trials must be performed according to the principles of Good Clinical Practice (GCP) and the trial sponsor has an obligation to ensure that all of the personnel involved in the trial have undergone training relevant to their role. Pathologists who are involved in the delivery of clinical trials are often required to undergo formal GCP training and may additionally undergo Good Clinical Laboratory Practice training if they are involved in the laboratory analysis of trials samples. Further training can be provided via trial-specific investigator meetings, which may be either multidisciplinary or discipline-specific events. Pathologists should also ensure that they undertake External Quality Assurance schemes relevant to the area of diagnostic practice required in the trial. The level of engagement of pathologists in academia and clinical trials research has declined in the United Kingdom over recent years. This paper recommends the optimal training and accreditation for pathologists undertaking clinical trials activities with the aim of facilitating increased engagement. Clinical trials training should ideally be provided to all pathologists through centrally organised educational events, with additional training provided to pathologists in training through local postgraduate teaching. Pathologists in training should also be strongly encouraged to undertake GCP training. It is hoped that these recommendations will increase the number of pathologists who take part in clinical trials research in order to ensure a high level and standard of data collection and to maximise the translational research opportunities.

Indexed as

PathologistsResearch PersonnelAccreditationHumansLaboratoriesPathology, ClinicalReproducibility of ResultsUnited Kingdomclinical trialsNCRI CM-Pathtraining and accreditation

Identifiers

PMID30680942
PMCPMC6463859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.